Advancements in Health Screening: Empowering Early Detection and Prevention

The rapidly growing health screening market addresses early disease detection and prevention, improving outcomes and reducing costs. This report explores emerging technologies like Multi Cancer Detection Assays and AI (Artificial Intelligence) in health screening.

BOSTON, July 10, 2024 /PRNewswire/ — “According to the latest BCC Research study, the demand for “Routine Health Screening Market” is expected to grow from $59.7 billion in 2024 and is projected to reach $82.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2024 to 2029.”

BCC Research Logo

The routine health screening market is experiencing robust growth driven by increasing focus on preventive healthcare and early disease detection. With a rising prevalence of non-communicable diseases like diabetes and cardiovascular disorders, coupled with a globally aging population, there is a growing demand for proactive health management solutions. Technological advancements, including AI-driven diagnostic tools, are enhancing the accuracy and accessibility of screenings, making them more widely available. The COVID-19 pandemic has further underscored the importance of regular health check-ups, boosting the market’s significance. Integration into corporate wellness programs and the trend towards personalized medicine are also fueling market expansion, positioning routine health screenings as crucial in proactive health management worldwide.

The following factors drive the global market for routine health screening:

Growing Prevalence of Chronic Diseases: The rise in chronic diseases such as diabetes, cardiovascular disease, and cancer has significantly increased the need for regular health check-ups. These screenings are essential for early detection and timely intervention, necessary for effective treatment of chronic diseases. Regular screening can prevent complications and improve patient outcomes by identifying risk factors and monitoring health status.

Growing Health Consciousness: Nowadays people know more about their health than ever before. Regular health screening is the way individuals can control their well development by identifying potential health problems in the first few days. This growing health awareness is supported by awareness campaigns, health education measures, and preventive measures, all of which contribute to increasing the tendency for routine health checks.

Advancements in Screening Technology: The development of technology has changed the methods of health examinations. Improved diagnostic tools such as advanced imaging techniques such as MRI and CT scans, genetic testing, and point-of-care devices have improved the accuracy and efficiency of screenings. These innovations enable earlier disease detection, more personalized risk assessments, and customized treatment plans, making health screenings more effective than ever before.

Request a Sample Copy of The global market for routine health screening reports.

Report Synopsis 

Report Metrics


Base year considered


Forecast Period considered


Base year market size

$56.6 billion

Market Size Forecast

$82.9 billion

Growth rate

CAGR of 6.8% for the forecast period of 2024-2029

Segment Covered

Test Type, Sample Type, Technology, and Region

Regions covered

North America, Europe, Asia-Pacific, and Rest of the World (RoW)

Countries covered

U.S., Canada, Germany, France, UK, Italy, Spain, China, India, Japan, Middle East, and Africa

Key Market Drivers


  • Growing prevalence of chronic diseases.
  • Growing health consciousness.
  • Advancements in screening technology.


Key Interesting Facts About the global market for routine health screening:

  1. AI in Ophthalmology:
    • Exceptional diagnostic capabilities in detecting retinal conditions, glaucoma, and other eye diseases.
    • State-of-the-art diagnostic systems built from fundus images.
    • Challenges in designing AI models with large imaging datasets.
    • Early detection of glaucoma through AI can lead to earlier intervention.
    • Potential to slow disease progression and reduce the risk of significant vision loss.
  2. Multicancer Detection (MCD) Assays:
    • Emerging development in routine health screening.
    • Highlighted in the AACR Cancer Progress Report 2023.
    • The study covers over 50 cancer types with a sample of more than 5,000 individuals with suspected symptoms.
    • Detected two-thirds of cancers.
    • Accurately identified the origin site in 85% of cases.
    • Modeling study based on cancer mortality data from England.
    • Potential to reduce annual cancer-related deaths by 17% with routine integration of MCDs.

The global market for routine health screening report includes in-depth data and analysis addressing the following important queries:

  1. What is the projected market size and growth rate of the market?
    The Global routine health screening market is projected to grow from $56.6 billion in 2023 to $82.9 billion in 2029, at a compound annual growth rate (CAGR) of 6.8% during the forecast period.

  2. What are the key factors driving the growth of the market?
    • Increase the prevalence of chronic diseases.
    • Increase in health awareness.
    • Advancements in technology.
  3. What segments are covered in the market?
    This report segments the market based on type, technology, sample, and region. The market is segmented based on the type into Cholesterol Screening, Diabetes Screening, Blood Pressure Tests, Cancer Screening, Prenatal screening, Vision and Hearing Screenings, Bone Density Tests, Thyroid Profile Tests, Essential Nutrients Tests, and Others. The market is segmented based on technology into QPCR (Quantitative Polymerase Chain Reaction), Q-FISH (Quantitative Fluorescence, in Situ Hybridization), Immunoassays, Medical Imaging, STELA (Single Telomere Length Analysis), and Others. The market is segmented into blood, urine, saliva, imaging samples, and others based on application. Based on region, the market is segmented into North America, Europe, Asia-Pacific, and the rest of the world.

  4. By Type, which segment will dominate the market by the end of 2029?
    Diabetes will dominate the market by the end of 2029.

  5. Which region has the highest market share in the market?
    North America holds the highest share of the market.

Some of the Key Market Players Are:


Browse More Related Reports:

Fetal Monitoring, Diagnostics, and Predictive Tests: This report offers a detailed analysis of the global market for fetal monitoring, diagnostics, and predictive tests, providing both quantitative and qualitative data. It aims to assist businesses in developing growth strategies, assessing the market landscape, analyzing their current market positions, and making informed decisions. The report includes historical data and future projections on sales segmented by application, product type, and end user. It covers several types of fetal monitoring, diagnostics, and predictive tests, detailing their current and historical market revenues. Additionally, the global market is categorized by region, including North America, Europe, and the Rest of the World. To enhance understanding, the report profiles the competitive landscape, highlighting key competitors and their respective market shares.

AI in Diabetes Management: Global Market Outlook: This report examines the global market for AI in diabetes management, segmenting it by product type, technique, and geographic region. It provides a comprehensive overview of market trends and uses 2021 as the base year for estimating market data and revenue projections for the forecast period from 2022 to 2027. Market values are calculated based on the total revenue generated by providers of AI-based diabetes management products. The scope of this study encompasses AI in diabetes management care platforms and associated services.

Directly Purchase a copy of the report with BCC Research.

For further information or to make a purchase, please get in touch with [email protected].  

About BCC Research

BCC Research provides objective, unbiased measurement and assessment of market opportunities with detailed market research reports. Our experienced industry analysts’ goal is to help you make informed business decisions, free of noise and hype.

Contact Us
Corporate HQ: 50 Milk St. Ste 16, Boston, MA 02109, USA
Email: [email protected],
Phone: +1 781-489-7301
For media inquiries, email [email protected] or visit our media page for access to our market research library.

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher 



Cision View original content:


Advancements in Health Screening: Empowering Early Detection and Prevention WeeklyReviewer

PR Newswire Science News

World Reviewer Staff
World Reviewer Staff
The first logical thought has to be "no way". I'm the World Observer! Ill find and share important news all day.

Latest articles

Earnings Disclosure

WeeklyReviewer earns primarily through affiliates and ads. We don’t encourage anyone to click on ads for any other purpose but your own. We recommend products and services often for our readers, and through many we will earn commissions through affiliate programs.

Related articles